🇺🇸 Tianeptine Sodium in United States

129 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Intentional Overdose — 22 reports (17.05%)
  2. Serotonin Syndrome — 14 reports (10.85%)
  3. Suicide Attempt — 14 reports (10.85%)
  4. Drug Abuse — 13 reports (10.08%)
  5. Respiratory Depression — 12 reports (9.3%)
  6. Depressed Level Of Consciousness — 11 reports (8.53%)
  7. Respiratory Failure — 11 reports (8.53%)
  8. Somnolence — 11 reports (8.53%)
  9. Stress Cardiomyopathy — 11 reports (8.53%)
  10. Anxiety — 10 reports (7.75%)

Source database →

Tianeptine Sodium in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Tianeptine Sodium approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Tianeptine Sodium in United States?

Jonathan A. Javitch, MD, PhD is the originator. The local marketing authorisation holder may differ — check the official source linked above.